PERRIGO Co plc
For the period ended Sep 26, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 26, 2026 · Filed Nov 4, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Goodwill and Intangible Assets
NOTE 8 -GOODWILL AND INTANGIBLE ASSETS
Goodwill
Changes in the carrying amount of goodwill, by reporting segment, were as follows (in millions):
| December 31, 2025 | Impairments(1) | Currency translation adjustments | September 26, 2026 | |
|---|---|---|---|---|
| Self Care | $1,113.9 | $(0.3) | $(13.4) | $1,100.2 |
| Specialty Care | 682.8 | (78.8) | (11.5) | 592.4 |
| Infant Formula | 66.3 | (66.3) | — | — |
| All Other | 187.2 | (187.2) | — | — |
| Total goodwill | $2,050.1 | $(332.6) | $(25.0) | $1,692.6 |
(1) We had accumulated goodwill impairments of $2,659.9 million and $2,327.3 million as of September 26, 2026 and December 31, 2025, respectively.
Reporting Unit Goodwill
Women’s Health, Infant Formula, and Oral Care Reporting Units
During the three months ended March 28, 2026, we changed our reporting segments to align with organizational structure changes intended to further enhance the execution of our strategic priorities. As a result of the change, we prepared a quantitative goodwill impairment test under the previous and newly established reporting units. We determined the carrying value of the Women’s Health, Infant Formula, and Oral Care reporting units exceeded their respective fair values. We recorded goodwill impairment charges of $77.4 million, $66.3 million, and $187.2 million in Women’s Health, Infant Formula, and Oral Care reporting units, respectively. This resulted in $107.1 million remaining goodwill in the Women’s Health reporting unit as of March 28, 2026, which is reported within the Specialty Care segment. The goodwill related to Infant Formula and Oral Care reporting units are fully impaired, and the respective goodwill balances for these reporting units have been reduced tozero.
Note 8
Intangible Assets
Intangible assets and related accumulated amortization consisted of the following(1) (in millions):
| September 26, 2026 | December 31, 2025 | |||
|---|---|---|---|---|
| Gross | AccumulatedAmortization | Gross | AccumulatedAmortization | |
| Indefinite-lived intangibles: | ||||
| Trademarks, trade names, and brands | $3.5 | $— | $3.5 | $— |
| In-process research and development | 0.1 | — | 1.1 | — |
| Total indefinite-lived intangibles | $3.6 | $— | $4.6 | $— |
| Definite-lived intangibles: | ||||
| Distribution and license agreements and supply agreements | $99.3 | $66.1 | $109.5 | $70.1 |
| Developed product technology, formulations, and product rights | 345.4 | 254.9 | 351.9 | 247.9 |
| Customer relationships and distribution networks | 1,754.1 | 1,232.3 | 1,845.5 | 1,257.2 |
| Trademarks, trade names, and brands | 2,346.0 | 853.8 | 2,446.3 | 826.5 |
| Non-compete agreements | — | — | 2.1 | 2.1 |
| Total definite-lived intangibles | $4,544.9 | $2,407.1 | $4,755.3 | $2,403.8 |
| Total intangible assets | $4,548.5 | $2,407.1 | $4,759.9 | $2,403.8 |
(1) Certain intangible assets are denominated in currencies other than U.S. dollar; therefore, their gross and net carrying values are subject to foreign currency movements.
We recorded amortization expense of $54.3 million and $163.3 million for the three and nine months ended September 26, 2026, respectively, and $55.8 million and $167.2 million for the three and nine months ended September 27, 2025, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.